Clinical Trial Update: Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence [Phase 2]

View source ↗

Summary

Phase 2 double-blind, placebo-controlled trial evaluating bupropion for methamphetamine dependence has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Dependence

Drugs mentioned

• bupropion (bupropion)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Methamphetamine Dependence | Phase 2 | Status: COMPLETED | Results posted: 2017-02-15